Assessment of Ovarian Cysts Using Machine Learning

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-01

Study Completion Date

2023-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims at creating a prediction model using machine learning algorithms that is capable of predicting malignant potential of ovarian cysts/masses based on patient characteristics, sonographic findings, and biochemical markers

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Gynacological Imaging Reporting and Data System in Ovarian Masses by Ultrasonography

NCT03175991

Ovarian Neoplasms

COMPLETED

Diagnostic Accuracy of Ultrasound and Tumors Markers in Diagnosis of Complex Ovarian Cysts

NCT07005089

Complex Ovarian Cyst

COMPLETED NA

Monitoring Ovarian Cysts in Pregnancy

NCT03440931

Ovarian Cysts

UNKNOWN

Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses

NCT00248820

Ovarian Tumor

UNKNOWN NA

The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cysts.

NCT03585309

Ovarian Endometrioma Ovary Cyst

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Ovarian cysts are one of the most common gynecologic disorders encountered in clinical practice. Approximately 20% of women may experience ovarian cysts at least once in their lifetime. However, incidence of significant ovarian cysts is 8% in premenopausal. In fact, many ovarian cysts are discovered incidentally while pelvic imaging is done for other indications. Interestingly, prevalence of ovarian cysts may reach up to 14-18% in menopausal women, many of which are likely persistent (2). Although most ovarian cysts are benign, definitive diagnosis cannot be made based on one time sonographic findings. Simple cysts are typically benign. Complex and solid cysts are still likely benign. However, malignancy is more common in this group of cysts. Definitive diagnosis by histopathology warrants surgical removal of the cyst/ovary. Because the condition is common and is mostly benign, surgery is not considered unless malignancy is reasonably a concern or the cyst is symptomatic.

Therefore, most ovarian cysts are expectantly managed. Aim of expectant management is to determine cyst changes. Follow-up may extend beyond a year. However, recommendations have not been consistent among internationally recognized guidelines, and different cut-offs of cyst size and different frequencies and durations of follow-up were considered (5, 6). Similarly, there are different systems that are adopted by these guidelines to triage women with ovarian cysts based on sonographic and biochemical indicators.

This project aims at creating a prediction model using machine learning algorithms that can be applied to women with ovarian cysts. The aim of this mode is to determine probability of cancer and management plan including surgery, long-term or short-term follow-up.

Retrieved records will be reviewed for eligibility. Patients will be considered for inclusion if they are postmenarchal, have documented follow-up for at least 1 year following initial presentation unless surgically managed, and provide authorization to use their medical records for research purposes. They should have received their care in the receptive centers. Women will be excluded from the study if they were admitted for an acute event including cyst torsion, rupture or hemorrhage with no prior documentation of ovarian cysts. Women with cysts smaller than 3 cm will not be eligible.

A standardized data collection spreadsheet is designed for the purpose of the study and will be shared with all contributing centers. Data collection will include patient demographics (e.g., age, parity, body mass index, ethnicity, smoking status), gynecologic history (e.g., menstrual abnormalities, contraceptive status), medical history (e.g., including chronic health issues and personal history of cancers), surgical history, family history of cancers including any diagnosed familial cancer syndromes. Specific information on current presentation will comprise presenting symptoms, if any, relevant physical signs, sonographic features (e.g., cyst size, side, consistency, locularity, presence of septa, solid areas, papillae, intracystic fluid texture, associated pelvic fluid or ascites), features noted in other imaging modalities if any, tumor markers (CA125, HCG, ALP, LDH,HE-4), management plan including surgical findings and histopathological diagnosis, follow-up including follow-up findings and cyst/mass complications during follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ovarian Cyst

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

prediction model

Data will be pre-processed prior to final analysis, including data cleaning, imputation of missing values, dimensionality reduction, and removal of outliers. Data will be utilized as Xi and Yi where Xi presents input (features) and Yi presents dependent variables (outcomes). Different classification algorithms will be tested for accuracy to build the final model including logistic regression, SVM, XGboost and random forest algorithms. Data will be split at 0.8:0.2 for model training and testing, respectively.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Females who are postmenarchal, have documented follow-up for at least 1 year following initial presentation unless surgically managed, and provide authorization to use their medical records for research purposes. They should have received their care in the receptive centers

Exclusion Criteria

Women will be excluded from the study if they were admitted for an acute event including cyst torsion, rupture or hemorrhage with no prior documentation of ovarian cysts. Women with cysts smaller than 3 cm will not be eligible.

Minimum Eligible Age

15 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes